天利科技 reported revenue of ¥0.28B for the period ended 2026-06-30, +19.9% year on year. Net income was ¥0.02B, a 6.4% net margin on a 15.3% gross margin. The largest revenue line is 保险产品服务 at 67% of the total. Free cash flow for the period was ¥0.08B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.28B | +19.9% |
| Gross profit | ¥0.04B | — |
| Operating income | ¥0.02B | — |
| Net income | ¥0.02B | +123.4% |
| Gross margin | 15.3% | Net margin 6.4% |
| Revenue Q/Q | +19.4% | — |
| Segment | Revenue | Share |
|---|---|---|
| 保险产品服务 | ¥0.18B | 66.6% |
| 移动信息服务 | ¥0.06B | 20.5% |
| 算力服务及贸易业务 | ¥0.04B | 12.9% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.23B | 84.7% |
| R&D | ¥0.00B | 1.3% |
| SG&A | ¥0.02B | 6.1% |
| Tax & other | ¥0.00B | 1.6% |
| Item | Amount |
|---|---|
| Total assets | ¥0.84B |
| Total liabilities | ¥0.30B |
| Shareholders' equity | ¥0.54B |
| Equity / assets | 63.7% |
| Operating cash flow | ¥0.08B |
| Capital expenditure | ¥0.00B |
| Free cash flow | ¥0.08B |
| Cash conversion (OCF / net income) | -1481% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
劲拓股份 ・ 花园生物 ・ 宝色股份 ・ 汉宇集团 ・ 博济医药 ・ 科隆股份 ・ 九强生物 ・ 凯发电气 ・ 道氏技术 ・ 正业科技 ・ 金盾股份 ・ 迦南科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies